← Eichor
Study identifier: NCT05737303 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Cancer

Condition: Epithelial Ovarian Carcinoma Stage III · Epithelial Ovarian Carcinoma Stage IV · Fallopian Tube Carcinoma Stage III  ·  Sponsor: Women's Hospital School Of Medicine Zhejiang University

PhasePhase 3
Planned participants538
Who can joinFemale, 18 Years to 75 Years
Healthy volunteersNo

About this study

The purpose of this study is to compare the efficacy and safety of nab-paclitaxel with solvent-based taxanes as first-line treatment for patients with advanced primary epithelial ovarian cancer (EOC), primary peritoneal carcinoma or fallopian tube carcinoma.

This description comes directly from the study's public registry record.

Talk to the study team

Yaxia Chen, MD  ·  +86-571-87061501  ·  chenyax@zju.edu.cn

Yang Li, MD  ·  +86-571-87061501  ·  li_yang@zju.edu.cn

Always discuss trial participation with your own doctor first.

Locations (11)

Sun Yat-Sen University Cancer HospitalGuangzhou, Guangdong, ChinaNot Yet Recruiting
Qilu Hospital of Shandong UniversityJi'nan, Shandong, ChinaNot Yet Recruiting
Yaxia ChenHangzhou, Zhejiang, ChinaRecruiting
Sir Run Run HospitalHangzhou, Zhejiang, ChinaNot Yet Recruiting
The First Affiliated Hospital of Medical College of Zhejiang UniversityHangzhou, Zhejiang, ChinaNot Yet Recruiting
The Second Affiliated Hospital of Medical College of Zhejiang UniversityHangzhou, Zhejiang, ChinaNot Yet Recruiting
Zhejiang Cancer HospitalHangzhou, Zhejiang, ChinaNot Yet Recruiting
Ningbo women's and children's HospitalNingbo, Zhejiang, ChinaNot Yet Recruiting
The No, 1 People's Hospital of NingboNingbo, Zhejiang, ChinaNot Yet Recruiting
The Second Affiliated Hospital of Wenzhou Medical UniversityWenzhou, Zhejiang, ChinaNot Yet Recruiting
The First Affiliated Hospital of Wenzhou Medical UniversityWenzhou, ChinaNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05737303